MAPI Research Trust provides reliable, comprehensive and up-to-date information services to research scientists, pharmaceutical companies, and governmental health agencies involved in the fields of Patient-Reported Outcomes (PRO) and Epidemiology worldwide.

Home SERVICES Questionnaire Licensing
ICQ (Inhaled corticosteroid Questionnaire Long Form)


Developed by:
Thys van der Molen (The Netherlands)

Objective:
To measure patients' inhaled corticosteroids (ICS) related side effect perceptions

Copyright:
ICQ © Thys van der Molen, 2006. All Rights Reserved.

Reference publication:
Foster, J, van Sonderen, E, Lee, A et al. A self-rating scale for patient-perceived side effects of inhaled corticosteroids. Respir Res. 2006; 7(1): 131


Conditions of use:


1. User Agreement:

User is required to complete and sign a User Agreement in which specific conditions requested by the Author are detailed.


2. Access fees

carre6 Author's royalty fees:

- For all non commercial, academic research and clinical purpose: free of charge

- In commercial studies: 5000 €* per protocol/application plus an administrative fee of 50 €* per available language version (original version and translated versions)

These fees are payable to MAPI Research Trust on behalf of Thys van der Molen.

Other specific conditions requested by the Author are detailed in the User Agreement.

carre6
Distribution fees are requested according to the study design and context of use of the questionnaire:

- In not-funded academic research (1) and individual clinical practice: free of charge

- In funded academic research (2): 300 €* per study + 50 €* per language-version requested

- In commercial studies (3) involving "for-profit" organizations: 600 €* per study + 250 €* per language version requested.


* excluding VAT

(1) Not funded academic research: if the project is not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds then fees are waived.

(2) Funded academic research: projects receiving funding from commerce, government, EU should anticipate paying the corresponding fees.

(3) Commercial studies (industry, CRO, any for-profit companies).


Review copy:

UK English version available for review purpose only. Please click here to access.


New translations:

For the production of new translations to be used in commercial studies, each translation shall be coordinated by Mapi Institute.


Contact information:

MAPI Research Trust

27 rue de la Villette
F - 69003 LYON
Tel: +33 4 72 13 65 75
Fax: +33 4 72 13 55 73

This e-mail address is being protected from spambots. You need JavaScript enabled to view it


Please have the User Agreement completed, dated and signed and return one original copy to MAPI Research Trust by post. As soon as we receive it, we will process your request.


More information on the ICQ on PROQOLID


[ BACK ]

 

2012 05 22

To access our catalog, please click here.

 

New questionnaires distributed by MAPI Research Trust

ACCEPT (Chronic Treatment Acceptance Questionnaire)
Registrat MAPI (France) and MAPI Consultancy

ADRQL (Alzheimer Disease Related Quality of Life)
Black Betty S, Kasper Judith D and Rabins Peter V. - Johns Hopkins Medical INstitutions (USA)

Barthel Index
Florence I. Mahoney and Dorothea W. Barthel.

ESS (Epworth Sleepiness Scale)
Murray W. Johns (Australia)

FIRST (Fibromyalgia Rapid Screening Tool)
Serge Perrot & Didier Bouhassira (France)

PDSS-2 (Parkinson's Disease Sleep Scale)
Ray Chaudhuri (UK), Claudia Trenkwalder (Germany), Ralf Kohnen (Germany)

Skindex questionnaire 
Mary-Margaret Chren (USA)

TRIM-D and TRIM-D Device (Treatment Related Impact Measure for Diabetes)
Novo Nordisk (Denmark)